MTHFR and MTRR genotype and haplotype analysis and colorectal cancer susceptibility in a case-control study from the Czech Republic

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 721, Issue 1, 2011, Pages 74-80

  Pardini, Barbara ^a   Kumar, Rajiv ^b   Naccarati, Alessio ^a   Prasad, Rashmi B ^b   Forsti, Asta ^b   Polakova, Veronika ^a   Vodickova, Ludmila ^a,c   Novotny, Jan ^d   Hemminki, Kari ^b   Vodicka, Pavel ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Colorectal cancer risk; Genotype; Haplotype analyses; MTHFR; MTRR

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); METHIONINE SYNTHASE REDUCTASE;

ADULT; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; CZECH REPUBLIC; FEMALE; FOLATE METABOLISM; GENE FUNCTION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CZECH REPUBLIC; FEMALE; FERREDOXIN-NADP REDUCTASE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79951669632     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2010.12.008     Document Type: Article

References (49)

1. Li F.Y., Lai M.D. Colorectal cancer, one entity or three. J. Zhejiang Univ. Sci. B 2009, 10:219-229.
2. Sharp L., Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am. J. Epidemiol. 2004, 159:423-443.
3. Xu X.L., Yu J., Zhang H.Y., Sun M.H., Gu J., Du X., Shi D.R., Wang P., Yang Z.H., Zhu J.D. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. World J. Gastroenterol. 2004, 10:3441-3454.
4. Lucock M. Is folic acid the ultimate functional food component for disease prevention?. BMJ 2004, 328:211-214.
5. Lucock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol. Genet. Metab. 2000, 71:121-138.
6. Kono S., Chen K. Genetic polymorphisms of methylenetetrahydrofolate reductase and colorectal cancer and adenoma. Cancer Sci. 2005, 96:535-542.
7. van der Put N.M., Gabreels F., Stevens E.M., Smeitink J.A., Trijbels F.J., Eskes T.K., van den Heuvel L.P., Blom H.J. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am. J. Hum. Genet. 1998, 62:1044-1051.
8. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J., den Heijer M., Kluijtmans L.A., van den Heuvel L.P., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 1995, 10:111-113.
9. Hazra A., Wu K., Kraft P., Fuchs C.S., Giovannucci E.L., Hunter D.J. Twenty-four non-synonymous polymorphisms in the one-carbon metabolic pathway and risk of colorectal adenoma in the Nurses' Health Study. Carcinogenesis 2007, 28:1510-1519.
10. Hubner R.A., Houlston R.S. MTHFR C677T and colorectal cancer risk: a meta-analysis of 25 populations. Int. J. Cancer 2007, 120:1027-1035.
11. Taioli E., Garza M.A., Ahn Y.O., Bishop D.T., Bost J., Budai B., Chen K., Gemignani F., Keku T., Lima C.S., Le Marchand L., Matsuo K., Moreno V., Plaschke J., Pufulete M., Thomas S.B., Toffoli G., Wolf C.R., Moore C.G., Little J. Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review. Am. J. Epidemiol. 2009, 170:1207-1221.
12. Gaughan D.J., Kluijtmans L.A., Barbaux S., McMaster D., Young I.S., Yarnell J.W., Evans A., Whitehead A.S. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 2001, 157:451-456.
13. Gemmati D., Ongaro A., Scapoli G.L., Della Porta M., Tognazzo S., Serino M.L., Di Bona E., Rodeghiero F., Gilli G., Reverberi R., Caruso A., Pasello M., Pellati A., De Mattei M. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. Cancer Epidemiol. Biomarkers Prev. 2004, 13:787-794.
14. Zavadakova P., Fowler B., Suormala T., Novotna Z., Mueller P., Hennermann J.B., Zeman J., Vilaseca M.A., Vilarinho L., Gutsche S., Wilichowski E., Horneff G., Kozich V. cblE type of homocystinuria due to methionine synthase reductase deficiency: functional correction by minigene expression. Hum. Mutat. 2005, 25:239-247.
15. Zhang Z., Shi Q., Liu Z., Sturgis E.M., Spitz M.R., Wei Q. Polymorphisms of methionine synthase and methionine synthase reductase and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Cancer Epidemiol. Biomarkers Prev. 2005, 14:1188-1193.
16. Stolzenberg-Solomon R.Z., Qiao Y.L., Abnet C.C., Ratnasinghe D.L., Dawsey S.M., Dong Z.W., Taylor P.R., Mark S.D. Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China. Cancer Epidemiol. Biomarkers Prev. 2003, 12:1222-1226.
17. Shi Q., Zhang Z., Li G., Pillow P.C., Hernandez L.M., Spitz M.R., Wei Q. Polymorphisms of methionine synthase and methionine synthase reductase and risk of lung cancer: a case-control analysis. Pharmacogenet. Genomics 2005, 15:547-555.
18. Gast A., Bermejo J.L., Flohr T., Stanulla M., Burwinkel B., Schrappe M., Bartram C.R., Hemminki K., Kumar R. Folate metabolic gene polymorphisms and childhood acute lymphoblastic leukemia: a case-control study. Leukemia 2007, 21:320-325.
19. Kwak S.Y., Kim U.K., Cho H.J., Lee H.K., Kim H.J., Kim N.K., Hwang S.G. Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population. Anticancer Res. 2008, 28:2807-2811.
20. Ohnami S., Sato Y., Yoshimura K., Sakamoto H., Aoki K., Ueno H., Ikeda M., Morizane C., Shimada K., Sakamoto Y., Esaki M., Saito I., Hirose H., Saito D., Sugimura H., Kosuge T., Okusaka T., Yoshida T. His595Tyr polymorphism in the methionine synthase reductase (MTRR) gene is associated with pancreatic cancer risk. Gastroenterology 2008, 135:477-488.
21. Collin S.M., Metcalfe C., Zuccolo L., Lewis S.J., Chen L., Cox A., Davis M., Lane J.A., Donovan J., Smith G.D., Neal D.E., Hamdy F.C., Gudmundsson J., Sulem P., Rafnar T., Benediktsdottir K.R., Eeles R.A., Guy M., Kote-Jarai Z., Morrison J., Al Olama A.A., Stefansson K., Easton D.F., Martin R.M. Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis. Cancer Epidemiol. Biomarkers Prev. 2009, 18:2528-2539.
22. Lissowska J., Gaudet M.M., Brinton L.A., Chanock S.J., Peplonska B., Welch R., Zatonski W., Szeszenia-Dabrowska N., Park S., Sherman M., Garcia-Closas M. Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses. Int. J. Cancer 2007, 120:2696-2703.
23. Suzuki T., Matsuo K., Hirose K., Hiraki A., Kawase T., Watanabe M., Yamashita T., Iwata H., Tajima K. One-carbon metabolism-related gene polymorphisms and risk of breast cancer. Carcinogenesis 2008, 29:356-362.
24. Tong S.Y., Lee J.M., Song E.S., Lee K.B., Kim M.K., Yun Y.M., Lee J.K., Son S.K., Lee J.P., Kim J.H., Hur S.Y., Kwon Y.I. The effects of polymorphisms in methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), and methionine synthase reductase (MTRR) on the risk of cervical intraepithelial neoplasia and cervical cancer in Korean women. Cancer Causes Control 2010, 21:23-30.
25. Koushik A., Kraft P., Fuchs C.S., Hankinson S.E., Willett W.C., Giovannucci E.L., Hunter D.J. Nonsynonymous polymorphisms in genes in the one-carbon metabolism pathway and associations with colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 2006, 15:2408-2417.
26. Steck S.E., Keku T., Butler L.M., Galanko J., Massa B., Millikan R.C., Sandler R.S. Polymorphisms in methionine synthase, methionine synthase reductase and serine hydroxymethyltransferase, folate and alcohol intake, and colon cancer risk. J Nutrigenet Nutrigenomics 2008, 1:196-204.
27. Theodoratou E., Farrington S.M., Tenesa A., McNeill G., Cetnarskyj R., Barnetson R.A., Porteous M.E., Dunlop M.G., Campbell H. Dietary vitamin B6 intake and the risk of colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 2008, 17:171-182.
28. Le Marchand L., Donlon T., Hankin J.H., Kolonel L.N., Wilkens L.R., Seifried A. B-vitamin intake, metabolic genes, and colorectal cancer risk (United States). Cancer Causes Control 2002, 13:239-248.
29. Matsuo K., Hamajima N., Hirai T., Kato T., Inoue M., Takezaki T., Tajima K. Methionine synthase reductase gene A66G polymorphism is associated with risk of colorectal cancer. Asian Pac. J. Cancer Prev. 2002, 3:353-359.
30. Otani T., Iwasaki M., Hanaoka T., Kobayashi M., Ishihara J., Natsukawa S., Shaura K., Koizumi Y., Kasuga Y., Yoshimura K., Yoshida T., Tsugane S. Folate, vitamin B6, vitamin B12, and vitamin B2 intake, genetic polymorphisms of related enzymes, and risk of colorectal cancer in a hospital-based case-control study in Japan. Nutr. Cancer 2005, 53:42-50.
31. Center M.M., Jemal A., Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol. Biomarkers Prev. 2009, 18:1688-1694.
32. Vasen H.F., Mecklin J.P., Khan P.M., Lynch H.T. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis. Colon Rectum 1991, 34:424-425.
33. Vasen H.F., Watson P., Mecklin J.P., Lynch H.T. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999, 116:1453-1456.
34. Singh H., Turner D., Xue L., Targownik L.E., Bernstein C.N. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA 2006, 295:2366-2373.
35. Schaid D.J., Rowland C.M., Tines D.E., Jacobson R.M., Poland G.A. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am. J. Hum. Genet. 2002, 70:425-434.
36. Cheah P.Y. Recent advances in colorectal cancer genetics and diagnostics. Crit. Rev. Oncol. Hematol. 2009, 69:45-55.
37. Tenesa A., Dunlop M.G. New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat. Rev. Genet. 2009, 10:353-358.
38. Friso S., Choi S.W. Gene-nutrient interactions in one-carbon metabolism. Curr. Drug Metab. 2005, 6:37-46.
39. Huang Y., Han S., Li Y., Mao Y., Xie Y. Different roles of MTHFR C677T and A1298C polymorphisms in colorectal adenoma and colorectal cancer: a meta-analysis. J. Hum. Genet. 2007, 52:73-85.
40. Houlston R.S., Tomlinson I.P. Polymorphisms and colorectal tumor risk. Gastroenterology 2001, 121:282-301.
41. Eussen S.J., Vollset S.E., Igland J., Meyer K., Fredriksen A., Ueland P.M., Jenab M., Slimani N., Boffetta P., Overvad K., Tjonneland A., Olsen A., Clavel-Chapelon F., Boutron-Ruault M.C., Morois S., Weikert C., Pischon T., Linseisen J., Kaaks R., Trichopoulou A., Zilis D., Katsoulis M., Palli D., Berrino F., Vineis P., Tumino R., Panico S., Peeters P.H., Bueno-de-Mesquita H.B., van Duijnhoven F.J., Gram I.T., Skeie G., Lund E., Gonzalez C.A., Martinez C., Dorronsoro M., Ardanaz E., Navarro C., Rodriguez L., Van Guelpen B., Palmqvist R., Manjer J., Ericson U., Bingham S., Khaw K.T., Norat T., Riboli E. Plasma folate, related genetic variants, and colorectal cancer risk in EPIC. Cancer Epidemiol Biomarkers Prev 2010, 19:1328-1340.
42. De Mattia E., Toffoli G. C677T and A1298C MTHFR polymorphisms, a challenge for antifolate and fluoropyrimidine-based therapy personalisation. Eur. J. Cancer 2009, 45:1333-1351.
43. Olteanu H., Munson T., Banerjee R. Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase. Biochemistry 2002, 41:13378-13385.
44. Crawford D.C., Nickerson D.A. Definition and clinical importance of haplotypes. Annu. Rev. Med. 2005, 56:303-320.
45. Mayer O., Simon J., Rosolova H. A population study of the influence of beer consumption on folate and homocysteine concentrations. Eur. J. Clin. Nutr. 2001, 55:605-609.
46. Vesela K., Pavlikova M., Janosikova B., Andel M., Zvarova J., Hyanek J., Kozich V. Genetic determinants of folate status in Central Bohemia. Physiol. Res. 2005, 54:295-303.
47. Pardini B., Naccarati A., Novotny J., Smerhovsky Z., Vodickova L., Polakova V., Hanova M., Slyskova J., Tulupova E., Kumar R., Bortlik M., Barale R., Hemminki K., Vodicka P. DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic. Mutat. Res. 2008, 638:146-153.
48. Landi D., Gemignani F., Naccarati A., Pardini B., Vodicka P., Vodickova L., Novotny J., Forsti A., Hemminki K., Canzian F., Landi S. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis 2008, 29:579-584.
49. Polakova V., Pardini B., Naccarati A., Landi S., Slyskova J., Novotny J., Vodickova L., Bermejo J.L., Hanova M., Smerhovsky Z., Tulupova E., Kumar R., Hemminki K., Vodicka P. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic. Hum. Mutat. 2009, 30:661-668.